U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H29FO4.H2O
Molecular Weight 394.4769
Optical Activity UNSPECIFIED
Defined Stereocenters 9 / 9
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FLUOCORTOLONE MONOHYDRATE

SMILES

O.[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]3([H])[C@@]2([H])C[C@H](F)C4=CC(=O)C=C[C@]34C

InChI

InChIKey=XMXIGEQXHQRVHJ-ABJXWZFZSA-N
InChI=1S/C22H29FO4.H2O/c1-11-6-14-13-8-16(23)15-7-12(25)4-5-21(15,2)20(13)17(26)9-22(14,3)19(11)18(27)10-24;/h4-5,7,11,13-14,16-17,19-20,24,26H,6,8-10H2,1-3H3;1H2/t11-,13+,14+,16+,17+,19-,20-,21+,22+;/m1./s1

HIDE SMILES / InChI

Molecular Formula C22H29FO4
Molecular Weight 376.4617
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 9 / 9
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including http://www.druginfosys.com/Drug.aspx?DrugCode=1121&DrugName=Fluocortolone&type=1

Fluocortolone is a topical corticosteroid (class of steroid hormones formed in the adrenal gland). Is primary indicated in condition like, Ana fissure, Dermatosis haemorrhoids, proctitis. The signs and symptoms that are produced after the acute overdosage include convulsions, respiratory arrest, allergic skin reactions. Glucocorticoids, such as fluocortolone, act through nuclear hormone receptors Schaaf and Cidlowski (2002). The two members of this family are glucocorticoid receptor (GR) type I and GR type I I. Activation of these sites alters gene expression of endogenous agents that influence immune and inflammatory responses.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions
PubMed

PubMed

TitleDatePubMed
Contact allergies to topical corticosteroids: 10 cases of contact dermatitis.
1991 Aug
Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial.
2001 Apr
Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomized prospective clinical trial.
2001 Jun
A case of cutaneous delayed-type allergy to oral dexamethasone and to betamethasone.
2002
Clocortolone pivalate cream 0.1% used concomitantly with tacrolimus ointment 0.1% in atopic dermatitis.
2003 Aug
[Bilateral uveitis intermedia. A 15-year clinical course].
2003 Dec
An integrative approach to eczema (atopic dermatitis).
2003 Jan-Feb
Orbital myositis in a patient with primary biliary cirrhosis: successful treatment with methotrexate and corticosteroids.
2003 Nov
Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
2004 Nov
Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study.
2005 Apr 27
Topical FK506 as immunoprophylaxis after allogeneic penetrating normal-risk keratoplasty: a randomized clinical pilot study.
2005 Feb
[Ranking of systemic steroids after normal-risk keratoplasty. Results of a randomized prospective study].
2005 May
Recurrent optic disc and retinal vasculitis in a patient with drug-induced urticarial vasculitis.
2006
Oral and intralesional steroid therapy in giant cell granuloma.
2006 Jun
[Sudden hearing loss in a patient with a 3-mm acoustic tumor].
2007
Varicella chorioretinitis.
2007 Dec
German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version).
2007 Jun
Transrepression and transactivation potencies of inhaled glucocorticoids.
2008 Dec
A simple and rapid ESI-LC-MS/MS method for simultaneous screening of doping agents in urine samples.
2009 Apr
Stenotrophomonas maltophilia induced post-cataract-surgery endophthalmitis: Outbreak investigation and clinical courses of 26 patients.
2009 Apr
[Retinochoroidopathy after intravitreal anti-VEGF treatment].
2009 Aug
Adalimumab for the treatment of fistulas in patients with Crohn's disease.
2009 Jul
Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study.
2009 Nov
Generic sample preparation combined with high-resolution liquid chromatography-time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories.
2010 Apr
A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves' orbitopathy.
2010 Jan
Prevention and treatment of intertrigo in large skin folds of adults: a systematic review.
2010 Jul 13
Update on the management of chronic eczema: new approaches and emerging treatment options.
2010 Jul 28
Operational post-keratopasty graft tolerance due to differential HLAMatchmaker matching.
2010 Nov 11
Patents

Sample Use Guides

adult: 0.025 %; Frequency: 8 hours
Route of Administration: Topical
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 18:17:16 GMT 2023
Edited
by admin
on Sat Dec 16 18:17:16 GMT 2023
Record UNII
Z9Y6DNY6M2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FLUOCORTOLONE MONOHYDRATE
Common Name English
Code System Code Type Description
FDA UNII
Z9Y6DNY6M2
Created by admin on Sat Dec 16 18:17:17 GMT 2023 , Edited by admin on Sat Dec 16 18:17:17 GMT 2023
PRIMARY
PUBCHEM
66605376
Created by admin on Sat Dec 16 18:17:17 GMT 2023 , Edited by admin on Sat Dec 16 18:17:17 GMT 2023
PRIMARY
SMS_ID
100000162566
Created by admin on Sat Dec 16 18:17:17 GMT 2023 , Edited by admin on Sat Dec 16 18:17:17 GMT 2023
PRIMARY
CAS
910908-82-6
Created by admin on Sat Dec 16 18:17:17 GMT 2023 , Edited by admin on Sat Dec 16 18:17:17 GMT 2023
NON-SPECIFIC STOICHIOMETRY
Related Record Type Details
ANHYDROUS->SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY